H15.051 Scleromalacia perforans, right eye

Name of the Condition

• Scleromalacia perforans, right eye
• Medical Term: Scleromalacia perforans
• ICD Code: H15.051

Summary

Scleromalacia perforans is a rare, necrotizing condition of the sclera, the tough outer layer of the eyeball, characterized by thinning and potential perforation. It often occurs in the setting of long-standing rheumatoid arthritis and may lead to serious ocular complications if not addressed. The condition requires careful evaluation to assess structural integrity and underlying systemic associations.

Causes

Scleromalacia perforans is most commonly associated with severe, long-standing rheumatoid arthritis, particularly in patients with seropositive disease. Other systemic inflammatory or autoimmune conditions may rarely contribute. The exact pathophysiology involves scleral necrosis, likely driven by immune complex deposition or vasculitis affecting the scleral vasculature.

Risk Factors

• Long-standing rheumatoid arthritis (especially seropositive)
• Chronic systemic inflammation
• Advanced age
• Female gender (more prevalent in women)

Symptoms

• Painless scleral thinning or visible scleral translucency
• Possible visible uveal tissue (e.g., choroid) through thinned sclera
• Asymptomatic in early stages; may progress to perforation
• Rarely, associated with ocular pain or redness if inflammation is present

Diagnosis

Diagnosis involves a comprehensive eye examination by an ophthalmologist, including slit-lamp biomicroscopy to assess scleral integrity and detect thinning or perforation. Ancillary tests such as ocular ultrasound or computed tomography (CT) may be used to evaluate scleral thickness and rule out associated complications. Laboratory testing for rheumatoid factor or other autoimmune markers may be considered to identify underlying systemic disease.

Treatment Options

Treatment focuses on managing the underlying systemic condition, such as rheumatoid arthritis, with immunosuppressive therapy. Local ocular interventions, including surgical repair of perforations or scleral grafting, may be necessary to preserve ocular structure and function. Pain management and anti-inflammatory medications may be used as adjuncts.

Prognosis and Follow-Up

Prognosis depends on the extent of scleral damage and the effectiveness of underlying disease management. Early intervention can prevent progression to perforation and vision loss. Regular follow-up with an ophthalmologist is essential to monitor for complications and adjust treatment as needed.

Complications

• Scleral perforation leading to uveal prolapse
• Vision loss or blindness
• Secondary infection (endophthalmitis)
• Chronic ocular pain or discomfort

Lifestyle & Prevention

• Maintain optimal management of rheumatoid arthritis or other systemic inflammatory conditions.
• Avoid eye trauma or excessive strain.
• Use protective eyewear in high-risk environments.
• Follow up regularly with a rheumatologist and ophthalmologist for systemic and ocular health.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision changes, eye pain, or visible protrusion of uveal tissue, as these may indicate perforation or other serious complications.

Tips for Medical Coders

Document the laterality (right eye) and confirm the presence of scleral thinning or perforation. Ensure underlying systemic conditions, such as rheumatoid arthritis, are clearly documented to support the diagnosis. Use H15.051 for right eye involvement; do not include laterality in the code if unspecified.